Follow up of Stroke Patients by Neurologists and General Practitioners

Stroke Clinical Trial

Official title:

Follow up of Stroke Patients by Neurologists and GP's: How Smooth is the Internal Communication and is There Room for Improvement?

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT05694403
• Other study ID #: 22258PSFU
• Status: Not yet recruiting
• Start date: September 1, 2023
• Est. completion date: June 30, 2024

Study information

• Verified date: August 2023
• Source: Vrije Universiteit Brussel
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

From the region around Brussels there are currently few data on how the post-stroke process take place and how satisfied the care providers are with it. For this reason, this survey is set up with the aim of examining four pillars: the epidemiology of stroke, communication between neurologists and GPs and satisfaction with it, secondary prevention of cardiovascular disease and control/treatment of the most common sequelae after stroke. In the latter two, the emphasis is on detection and treatment, and explicitly on whose task this is (neurologist versus GP), with the aim of verifying the mutual consensus on treatment and the subsequent detection of treatment shortcomings. This study will mainly consist of interviewing general practitioners and neurologists in the periphery of Brussels. This will be done by means of partly structured questionnaires, that will be send out to the medical professionals by contact with the central umbrella organisations of neurology in the hospitals and contact with the various general practitioners' practices (directly or through the multidisciplinary meetings per region). The questionnaires will be made up in google forms, as this programme allows efficient data processing, is eas-ily understandable for every participant and as no individual patient data will be processed.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 100
• Est. completion date: June 30, 2024
• Est. primary completion date: June 1, 2024
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 24 Years to 70 Years

Eligibility

Inclusion Criteria:

• Neurologist and/or general practitioner

Exclusion Criteria:

• Not actively treating stroke patients

Related Conditions & MeSH terms

• Stroke

Intervention

Other:
• Survey
Questionnaire

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Vrije Universiteit Brussel

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	secondary prevention stroke: Antithrombotics	Given that the purpose of our study is not to determine which antithrombotics are started, this will not be determined. What will be asked, however, is which healthcare provider starts this and whose task this is considered to be. Values will be reflected in ratios and percentages (%) of healthcare providers (both differences interdisciplinary and intradisciplinary)	1,5 - 2 years
Primary	secondary prevention stroke: Hypertension	This study will ask who starts antihypertensive drugs, whose task this is considered, how blood pressure is monitored and what the target values are. Values will be reflected in ratios and percentages (%) of healthcare providers (both differences interdisciplinary and intradisciplinary)	1,5 - 2 years
Primary	secondary prevention stroke: Smoking	The questionnaire will ask whether healthcare providers themselves actively detect smoking behaviour and how this smoking behaviour is addressed. (ex. via medication, consultation with tabacologist etc) Values will be reflected in ratios and percentages (%) of healthcare providers (both differences interdisciplinary and intradisciplinary)	1,5 - 2 years
Primary	secondary prevention stroke: Diabetes	The questionnaire will ask whether diabetes is actively detected by the healthcare provider himself, whether the treatment is subsequently started/adjusted himself and whose task this is according to them (neurologist, GP, diabetologist,...); At the end, it will also be asked whether healthcare providers would like to see changes in secondary prevention of stroke (open question, all answers will be checked) and whether the healthcare provider considers themselves to be capable enough to follow up secondary prevention in stroke patients (as this seems to be a good measure of the quality of currently available guidelines). Values will be reflected in ratios and percentages (%) of healthcare providers (both differences interdisciplinary and intradisciplinary)	1,5 - 2 years
Primary	secondary prevention stroke: general	At the end, it will also be asked whether healthcare providers would like to see changes in secondary prevention of stroke (open question, all answers will be checked) and whether the healthcare provider considers themselves to be capable enough to follow up secondary prevention in stroke patients (as this seems to be a good measure of the quality of currently available guidelines). Values will be reflected in ratios and percentages (%) of healthcare providers (both differences interdisciplinary and intradisciplinary)	1,5 - 2 years
Primary	sequelae of stroke: Fatigue	During the study, it will check whether fatigue is detected (example: if the treating physician often actively asks the patiënt for mental and/or physical fatigue) and what treatment is instituted. (example: psychologist, physiotherapy,...) Values will be reflected in ratios and percentages (%) of healthcare providers (both differences interdisciplinary and intradisciplinary)	1,5 - 2 years
Primary	sequelae of stroke: Depression	The questionnaire will explore whether depression itself is detected by the healthcare provider, how this is done (screening questions, heteroanamnesis,...), whose job it is and whether a referral is made and to whom. Values will be reflected in ratios and percentages (%) of healthcare providers (both differences interdisciplinary and intradisciplinary)	1,5 - 2 years
Primary	sequelae of stroke: Sexual dyfunction	This study will evaluate whether sexual dysfunction is being asked, whether and what treatment is initiated. (example: medication, couples therapy etc.) Values will be reflected in ratios and percentages (%) of healthcare providers (both differences interdisciplinary and intradisciplinary)	1,5 - 2 years